World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
82
Citations
19845
World Ranking
3763
National Ranking
1861

Mark R. Kelley publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Mark R. Kelley sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 277 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Mark R. Kelley D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Mark R. Kelley sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 82 D-Index — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Mark R. Kelley is affiliated with Indiana University in the United States and has a research portfolio spanning biochemistry, genetics, molecular biology, and medicine. Their published work centers on molecular biology, cancer research, neurology, oncology, and physiology, reflecting a multidisciplinary approach to biomedical sciences.

The scientist's main fields of study include:

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

Subfields of study represented in their research are:

  • Molecular Biology
  • Cancer Research
  • Neurology
  • Oncology
  • Physiology

The primary topics explored by Mark R. Kelley encompass:

  • Cancer, Hypoxia, and Metabolism
  • Neurofibromatosis and Schwannoma Cases
  • Adenosine and Purinergic Signaling
  • CO2 Sequestration and Geologic Interactions
  • Cancer Treatment and Pharmacology
  • Retinal Development and Disorders
  • Retinal Diseases and Treatments

Their contributions have appeared in several frequent publication venues, including:

  • OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
  • Cancer Research
  • Journal of Cellular Signaling
  • Gastroenterology
  • British Journal of Cancer

Some of the notable recent papers by Mark R. Kelley are:

  • "Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update," 2020, Journal of Clinical Oncology
  • "Ref-1 redox activity alters cancer cell metabolism in pancreatic cancer: exploiting this novel finding as a potential target," 2021, Journal of Experimental & Clinical Cancer Research
  • "Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours," 2021, British Journal of Cancer
  • "APE1/Ref-1 as a Novel Target for Retinal Diseases," 2021, Journal of Cellular Signaling
  • "Combined inhibition of Ref-1 and STAT3 leads to synergistic tumour inhibition in multiple cancers using 3D and in vivo tumour co-culture models," 2020, Journal of Cellular and Molecular Medicine

Frequent collaborators in their research include:

  • Melissa L. Fishel
  • Silpa Gampala
  • Randall Wireman
  • Olivia Babb
  • Millie M. Georgiadis

Best Publications

  • Going APE over ref-1.

    Angela R. Evans;Melissa Limp-Foster;Mark R. Kelley

  • Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update

    Charles L. Loprinzi;Christina Lacchetti;Jonathan Bleeker;Guido Cavaletti

  • The many functions of APE1/Ref-1: Not only a DNA repair enzyme

    Gianluca Tell;Franco Quadrifoglio;Claudio Tiribelli;Mark R. Kelley

  • Endosomolytic Polymersomes Increase the Activity of Cyclic Dinucleotide STING Agonists to Enhance Cancer Immunotherapy

    Daniel Shae;Kyle W. Becker;Plamen Christov;Dong Soo Yun

  • The intracellular localization of APE1/Ref-1: more than a passive phenomenon?

    Gianluca Tell;Giuseppe Damante;David Caldwell;Mark R. Kelley

  • Selenomethionine regulation of p53 by a ref1-dependent redox mechanism.

    Young R. Seo;Mark R. Kelley;Martin L. Smith

  • The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target

    Melissa L. Fishel;Mark R. Kelley

  • DNA repair in neurons: So if they don’t divide what's to repair?

    Melissa L. Fishel;Michael R. Vasko;Mark R. Kelley

  • Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition.

    Dong Wang;Meihua Luo;Mark R. Kelley

  • Inhibition of Inflammatory Signaling in Tet2 Mutant Preleukemic Cells Mitigates Stress-Induced Abnormalities and Clonal Hematopoiesis

    Zhigang Cai;Jonathan J. Kotzin;Baskar Ramdas;Sisi Chen

  • Altered Expression of Ape1/ref-1 in Germ Cell Tumors and Overexpression in NT2 Cells Confers Resistance to Bleomycin and Radiation

    Kent A. Robertson;Heather A. Bullock;Yi Xu;Renee Tritt

  • APE1/Ref-1 Interacts with NPM1 within Nucleoli and Plays a Role in the rRNA Quality Control Process

    Carlo Vascotto;Damiano Fantini;Milena Romanello;Laura Cesaratto

  • Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer.

    Mark R. Kelley;Liang Cheng;Richard Foster;Renee Tritt

  • Update on Late Relapse of Germ Cell Tumor: A Clinical and Molecular Analysis

    David W. George;Richard S. Foster;Robert A. Hromas;Robert A. Hromas;Kent A. Robertson

  • The embryonic stem cell transcription factors Oct-4 and FoxD3 interact to regulate endodermal-specific promoter expression

    Ying Guo;Robert Costa;Heather Ramsey;Trevor Starnes

  • Role of the multifunctional DNA repair and redox signaling protein Ape1/Ref-1 in cancer and endothelial cells: small-molecule inhibition of the redox function of Ape1.

    Meihua Luo;Sarah Delaplane;Aihua Jiang;April Reed

  • Enhanced Mitochondrial DNA Repair and Cellular Survival after Oxidative Stress by Targeting the Human 8-Oxoguanine Glycosylase Repair Enzyme to Mitochondria

    Allison W. Dobson;Yi Xu;Mark R. Kelley;Susan P. LeDoux

  • APE1/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1.

    Mark R. Kelley;Millie M. Georgiadis;Melissa L. Fishel

  • Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide.

    Melissa L. Fishel;Ying He;Martin L. Smith;Mark R. Kelley

  • The multifunctional DNA repair/redox enzyme Ape1/Ref-1 promotes survival of neurons after oxidative stress.

    Michael R. Vasko;Chunlu Guo;Mark R. Kelley

Frequent Co-Authors

Michael R. Vasko
Michael R. Vasko Indiana University
Gianluca Tell
Gianluca Tell University of Udine
Giuseppe Damante
Giuseppe Damante University of Udine
Franco Quadrifoglio
Franco Quadrifoglio University of Udine
Claudiu T. Supuran
Claudiu T. Supuran University of Florence
Susan P. LeDoux
Susan P. LeDoux University of South Alabama
Glenn L. Wilson
Glenn L. Wilson University of South Alabama
Reuben Kapur
Reuben Kapur Indiana University
David A. Williams
David A. Williams Boston Children's Hospital
David M. Wilson
David M. Wilson AstraZeneca (United Kingdom)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Mark R. Kelley

Trending Scientists

Recently Published Articles